Epetraborole not checked
AN2 Therapeutics, Inc · AN2-501971
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Polycythemia Vera (SNOMED CT: 109992005)
- Main trialPhase 2
- “This is a Phase 2 trial to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of oral epetraborole tablets for the treatment of adults with phlebotomy-dependent polycythemia vera (PV). The trial is designed to confirm the safety profile of oral epetraborole in the PV patient population and to identify 1 or more oral epetraborole doses for the treatment of phlebotomy-dependent PV. The study consists of an open-label Sentinel Cohort, an open-label Dose Selection Cohort (Part 1), followed by a double-blind, randomized, Placebo-Controlled Cohort (Part 2), and an…”In the company’s words, NCT07891533 on ClinicalTrials.gov
- Other names
- AN2-501971 · Therapeutic · Supratherapeutic
Other drugs for Polycythemia Vera (SNOMED CT: 109992005)
- GivinostatItalfarmaco · Phase 3
- RusfertideProtagonist Therapeutics, Inc. · Phase 3
- AG-236Agios Pharmaceuticals, Inc. · Phase 2/3
- BomedemstatMerck & Co. · Phase 3
- Ropeginterferon alfa-2bPharmaEssentia · Phase 3
- Flonoltinib MaleateChengdu Zenitar Biomedical Technology Co., Ltd · Phase 2
Coming up1
- Apr 2029Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials5
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Not yet recruiting | Apr 2029 | Phase 2 Study of Oral Epetraborole in Adults With Polycythemia Vera | |
| Phase 2/3Terminated | 18 Dec 2024 | Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease | |
| Phase 1Completed | 26 Feb 2022 | Phase 1 Study of Epetraborole Tablets | |
| Phase 1Completed | 10 Jun 2022 | A Study of Epetraborole Tablets in Subjects With Degrees of Renal Function | |
| Phase 1Completed | 26 Jul 2023 | A Study to Assess the Effects of Epetraborole on the QT Interval in Healthy Adult Subjects |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026